Dead or alive? Is viability alone enough?

Cell count and viability in cell therapy

Presenter: Greg Fendley, PhD / Senior Field Application Scientist 

A reliable cell count and viability is critical to the development and release of cell therapy products.

In this webinar, we look at: 

• The history of cell therapy, how it has emerged as a driver in the biopharma industry
• Factors to consider when assessing the overall health and viability of a cell therapy product
• Different modes of cell death, describe the pathways involved and identify the systematic events that lead a cell to the point of no return
• Automated methods and cell-based assays to measure cell death
• How dying cells may initially register as viable, yet become functionally dead in downstream processes

Watch our webinar “Dead or alive? Is viability alone enough?” below